Free morning briefing · 07:30 weekdays
The RNS that moves prices, in your inbox before the open.
AI-ranked movers and high-impact RNS across the FTSE 100, 250, SmallCap and AIM — one short email, every market day.
Get the briefing
TSTL

Tristel plc

TSTLLSEUnited KingdomHealthcareMedical Instruments & SuppliesFTSE AIM 100

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other.…more

P/E25.69xP/B5.85xROIC26.2%Dividend yield3.4%
£197.58M
Market Cap
EV: £188.76M
MOM6
QUAL10
VAL4
RSK3
TSTL
£197.58M
Market Cap · EV £188.76M

Tristel plc

MOM6
QUAL10
VAL4
RSK3

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other.…more

Latest RNS from Tristel plc

All TSTL news → · RNS daily feed

Analyst consensus: Buy

As of 22 Sept 2026, 6 analysts rate Tristel plc a Buy, with 83% buy ratings and a mean price target of 475p (range 400p–560p), +16% vs the current price.

Strong buy: 0Buy: 5Hold: 1Sell: 0Strong sell: 0

Full analyst history →

Valuation vs peers

Peer-relative fair value estimate: 250p against a current price of 408p (-39%), based on EV/EBITDA.

More Healthcare companies